Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.21.1
Stockholders' Equity (Tables)
 3 Months Ended
Mar. 31, 2021
Equity [Abstract]  
Schedule of Stock Options Activity

The following table summarizes stock options activity during the three months ended March 31, 2021 for the 2010 Plan, 2010 Director Plan and 2018 Stock Plan (in thousands, except per share data):

 

    Number of Shares     Weighted Average Exercise Price     Weighted Average Remaining Contractual Life
(in years)		     Total Intrinsic Value  
Outstanding as of January 1, 2021     3,795     $ 2.21       3.4     $ 26,441  
Granted     -       -       -       -  
Outstanding as of March 31, 2021     3,795     $ 2.21       3.2     $ 19,828  
Options vested and exercisable     3,273     $ 1.90       2.7     $ 18,085  
Schedule of Warrant Activity

The following table summarizes warrants activities during the three months ended March 31, 2021 (in thousands, except per share data).

 

    Number of Shares     Weighted Average Exercise Price     Weighted Average Remaining Contractual Life
(in years)		  
Outstanding as of January 1, 2021     450     $ 3.22       2.7  
Warrants granted     455       12.83       3.0  
Outstanding as of March 31, 2021     905     $ 8.05       2.6  
Warrants vested and exercisable     680     $ 9.65       2.7  
Summary of Weighted Average Assumptions Used in Determining Fair Value of Warrants

The following table summarizes weighted average assumptions used in determining the fair value of the warrants at the date of grant during the three months ended March 31, 2021:

 

    For the three months ended  
    March 31, 2021  
Exercise price   $ 12.83  
Expected term (years)     3.0  
Expected stock price volatility     81 %
Risk-free rate of interest     0 %
Expected dividend yield (per share)     0 %